XMLWordPrintable

    • Icon: EC eCQMs - Eligible Clinicians EC eCQMs - Eligible Clinicians
    • Resolution: Answered
    • Icon: Moderate Moderate
    • None
    • None
    • Laura Orr
    • 480 394-0200
    • ARIZONA STATE UROLOGICAL INSTITUTE
    • Hide
      Thank you for your question related to CMS646v5. In order for a patient to meet the numerator for this measure, they must have Intravesical Bacillus-Calmette Guerin (BCG) initiated within 6 months of bladder cancer staging. In the measure logic, this is specified as first dose of BCG administered 6 months or less after the date of the first bladder cancer staging procedure.
      Show
      Thank you for your question related to CMS646v5. In order for a patient to meet the numerator for this measure, they must have Intravesical Bacillus-Calmette Guerin (BCG) initiated within 6 months of bladder cancer staging. In the measure logic, this is specified as first dose of BCG administered 6 months or less after the date of the first bladder cancer staging procedure.
    • CMS0646v5
    • CMS0646v4
    • Need to set up measure for 2025

      Would you kindly give comprehensive guidance on how to satisfy the CMS646v4 eCQM measure's numerator condition? If you could outline the precise requirements that must be fulfilled in order to receive a positive result for this measure, that would be beneficial.

            AIR EC eCQM Team AIR EC eCQM Team
            lauraorr Laura Orr (Inactive)
            Votes:
            0 Vote for this issue
            Watchers:
            3 Start watching this issue

              Created:
              Updated:
              Resolved:
              Solution Posted On: